Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06054321
NA

Psychopharmacotherapy for Depressive Patients

Sponsor: Chonnam National University Hospital

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to compare the short (12 week) and long-term (1-year) efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the multimodal serum biomarker scores.

Official title: A Randomized Clinical Trial of Response to Psychopharmacotherapy According to Multimodal Serum Biomarkers in Depressive Patients

Key Details

Gender

All

Age Range

19 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2022-08-03

Completion Date

2030-12-31

Last Updated

2024-04-18

Healthy Volunteers

No

Interventions

DRUG

stepwise pharmacotherapy

In the stepwise pharmacotherapy group, treatment strategies (augmentation with antipsychotics (aripiprazole), augmentation with mood stabilizer (lithium),combination (mirtazapine)) will be determined every 3 weeks.

DRUG

antidepressant monotherapy group

In the antidepressant monotherapy group, dosage escalation will be determined every 3 weeks.

Locations (1)

Chonnam National University Hospital

Gwangju, South Korea